| scholarly article | Q13442814 |
| P50 | author | José Alvarez-Sabín | Q37369429 |
| Marc Ribo | Q40066212 | ||
| P2093 | author name string | A Evangelista | |
| M Quintana | |||
| E Santamarina | |||
| J Montaner | |||
| O Maisterra | |||
| P Delgado | |||
| C A Molina | |||
| A Penalba | |||
| T García-Berrocoso | |||
| T González-Alujas | |||
| P2860 | cites work | Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment | Q22306370 |
| Thrombin generation in non-cardioembolic stroke subtypes: the Hemostatic System Activation Study | Q28212776 | ||
| Plasma measurement of D-dimer levels for the early diagnosis of ischemic stroke subtypes. | Q34161318 | ||
| Prognostic significance of admission levels of troponin I in patients with acute ischaemic stroke. | Q35483503 | ||
| Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies | Q35674441 | ||
| Cardiac troponins in the intensive care unit: common causes of increased levels and interpretation | Q36700029 | ||
| Applicability of biomarkers in ischemic stroke. | Q36986354 | ||
| Blood biomarkers in the diagnosis of ischemic stroke: a systematic review | Q37227913 | ||
| State of the art: using natriuretic peptide levels in clinical practice | Q37257460 | ||
| Invited article: searching for oracles? Blood biomarkers in acute stroke. | Q37571237 | ||
| Role of routine transthoracic echocardiography in evaluation and management of stroke | Q40855353 | ||
| Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. | Q43529232 | ||
| Creatine kinase-MB elevation after stroke is not cardiac in origin: comparison with troponin T levels | Q43847098 | ||
| Brain natriuretic peptide is a marker associated with thrombus in stroke patients with atrial fibrillation | Q43989303 | ||
| Specific markers of myocardial injury in acute stroke | Q44219672 | ||
| Stroke subtype classification to mechanism-specific and undetermined categories by TOAST, A-S-C-O, and causative classification system: direct comparison in the North Dublin population stroke study. | Q48144818 | ||
| B-type natriuretic peptide in cardiovascular disease | Q48237778 | ||
| Brain natriuretic peptide as a predictor of delayed atrial fibrillation after ischaemic stroke and transient ischaemic attack | Q48428506 | ||
| Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction | Q48628464 | ||
| High plasma brain natriuretic polypeptide level as a marker of risk for thromboembolism in patients with nonvalvular atrial fibrillation | Q48638459 | ||
| Therapeutic strategies after examination by transesophageal echocardiography in 503 patients with ischemic stroke | Q48671344 | ||
| Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study | Q48691914 | ||
| Plasma brain natriuretic peptide can be a biological marker to distinguish cardioembolic stroke from other stroke types in acute ischemic stroke | Q48720340 | ||
| Drop in plasma brain natriuretic peptide levels after successful direct current cardioversion in chronic atrial fibrillation. | Q48894819 | ||
| Brain natriuretic peptide as a surrogate marker for cardioembolic stroke with paroxysmal atrial fibrillation | Q48921662 | ||
| Therapy implications of transthoracic echocardiography in acute ischemic stroke patients. | Q51438666 | ||
| Coagulation-fibrinolysis abnormalities in acute and chronic phases of cerebral thrombosis and embolism | Q68435790 | ||
| Hemorrhagic transformation in cerebral embolism | Q69605427 | ||
| Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke | Q71013917 | ||
| Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation | Q74044840 | ||
| Treatment of acute ischemic stroke | Q74271135 | ||
| Aortic spontaneous echocardiographic contrast and hemostatic markers in patients with nonrheumatic atrial fibrillation | Q77613336 | ||
| Transesophageal echocardiography is superior to transthoracic echocardiography in management of patients of any age with transient ischemic attack or stroke | Q80199079 | ||
| Hemostatic markers and platelet aggregation factors as predictive markers for type of stroke and neurological disability following cerebral infarction | Q81799170 | ||
| Comparison of transthoracic echocardiography using second harmonic imaging, transcranial Doppler and transesophageal echocardiography for the detection of patent foramen ovale in stroke patients | Q81801942 | ||
| Plasma B-type natriuretic peptide levels and recurrent arrhythmia after successful ablation of lone atrial fibrillation | Q84018417 | ||
| P433 | issue | 12 | |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 2538-2545 | |
| P577 | publication date | 2012-05-17 | |
| P1433 | published in | Journal of Neurology | Q6295649 |
| P1476 | title | Biomarker level improves the diagnosis of embolic source in ischemic stroke of unknown origin | |
| P478 | volume | 259 |
| Q64954488 | Atrial fibrillation in cryptogenic stroke and transient ischaemic attack – The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Rationale and design. |
| Q26861828 | B-type natriuretic peptides and mortality after stroke: a systematic review and meta-analysis |
| Q38188010 | Cardioembolic stroke diagnosis using blood biomarkers |
| Q26752352 | Embolic Strokes of Unknown Source and Cryptogenic Stroke: Implications in Clinical Practice |
| Q44447737 | Embolic strokes of undetermined source: the case for a new clinical construct |
| Q93164255 | Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke |
| Q38270771 | Neuroendocrine hormones as prognostic biomarkers in the setting of acute stroke: overcoming the major hurdles. |
Search more.